These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15253568)

  • 1. On the catalytic activity of autoantibodies in multiple sclerosis.
    Ponomarenko NA; Durova OM; Vorob'ev II; Suchkov SV; Gabibov AG
    Dokl Biochem Biophys; 2004; 395():120-3. PubMed ID: 15253568
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis.
    Polosukhina DI; Kanyshkova TG; Doronin BM; Tyshkevich OB; Buneva VN; Boiko AN; Gusev EI; Favorova OO; Nevinsky GA
    J Cell Mol Med; 2004; 8(3):359-68. PubMed ID: 15491511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.
    Misikov VK; Kimova MV; Durova OM; Gabibov AG; Suchkov SV; Vorobev II; Ponomarenko NA
    Bull Exp Biol Med; 2005 Jan; 139(1):85-8. PubMed ID: 16142285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of catalytic autoantibodies in neurodegenerative processes.
    Belogurov AA; Kurkova IN; Misikov VK; Suchkov SV; Telegin GB; Alekhine AI; Goncharov NG; Knorre VD; Gabibov AG; Ponomarenko NA
    Dokl Biochem Biophys; 2007; 413():61-4. PubMed ID: 17546954
    [No Abstract]   [Full Text] [Related]  

  • 5. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
    Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
    J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic antibodies in clinical and experimental pathology: human and mouse models.
    Ponomarenko NA; Durova OM; Vorobiev II; Aleksandrova ES; Telegin GB; Chamborant OG; Sidorik LL; Suchkov SV; Alekberova ZS; Gnuchev NV; Gabibov AG
    J Immunol Methods; 2002 Nov; 269(1-2):197-211. PubMed ID: 12379362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis].
    Salafet OV; Ruzina ND; Ponomarenko NA; Friboulet A; Kimova MV; Shmidt TE; Gabibov AG; Morse HK; Pal'tsev MA; Suchkov SV
    Vestn Ross Akad Med Nauk; 2010; (4):8-15. PubMed ID: 20540348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.
    Ponomarenko NA; Durova OM; Vorobiev II; Belogurov AA; Telegin GB; Suchkov SV; Misikov VK; Morse HC; Gabibov AG
    Immunol Lett; 2006 Feb; 103(1):45-50. PubMed ID: 16297986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioluminescent aptamer-based sandwich-type assay of anti-myelin basic protein autoantibodies associated with multiple sclerosis.
    Krasitskaya VV; Chaukina VV; Abroskina MV; Vorobyeva MA; Ilminskaya AA; Kabilov MR; Prokopenko SV; Nevinsky GA; Venyaminova AG; Frank LA
    Anal Chim Acta; 2019 Aug; 1064():112-118. PubMed ID: 30982509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis.
    Legostaeva GA; Polosukhina DI; Bezuglova AM; Doronin BM; Buneva VN; Nevinsky GA
    J Cell Mol Med; 2010 Mar; 14(3):699-709. PubMed ID: 19438809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of IgG- and sIgA-Abzymes capable of hydrolyzing histone H1.
    Kit YY; Starykovych MA; Richter VA; Stoika RS
    Biochemistry (Mosc); 2008 Aug; 73(8):950-6. PubMed ID: 18774943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.
    Ponomarenko NA; Durova OM; Vorobiev II; Belogurov AA; Kurkova IN; Petrenko AG; Telegin GB; Suchkov SV; Kiselev SL; Lagarkova MA; Govorun VM; Serebryakova MV; Avalle B; Tornatore P; Karavanov A; Morse HC; Thomas D; Friboulet A; Gabibov AG
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):281-6. PubMed ID: 16387849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study for isolation of catalytic antibodies by histidine ligand affinity chromatography as an alternative to conventional protein A/G methods.
    Nedonchelle E; Pitiot O; Vijayalakshmi MA
    Appl Biochem Biotechnol; 2000; 83(1-3):287-94; discussion 294-5, 297-313. PubMed ID: 10826967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.
    Brokstad KA; Page M; Nyland H; Haaheim LR
    Acta Neurol Scand; 1994 Jun; 89(6):407-11. PubMed ID: 7526591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody reaction to myelin basic protein by plasma parvovirus B19 IgG in MS patients.
    Thomas G; Rael L; Shimonkevitz R; Melamed I; Bar-Or D
    Protein Pept Lett; 2006; 13(2):109-11. PubMed ID: 16472070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies with enzymatic properties in human autoimmune diseases.
    Wootla B; Lacroix-Desmazes S; Warrington AE; Bieber AJ; Kaveri SV; Rodriguez M
    J Autoimmun; 2011 Sep; 37(2):144-50. PubMed ID: 21624820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic activity of anti-thyroglobulin antibodies.
    Li L; Kaveri S; Tyutyulkova S; Kazatchkine MD; Paul S
    Ann N Y Acad Sci; 1995 Sep; 764():570-2. PubMed ID: 7486587
    [No Abstract]   [Full Text] [Related]  

  • 20. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis.
    Saveliev AN; Ivanen DR; Kulminskaya AA; Ershova NA; Kanyshkova TG; Buneva VN; Mogelnitskii AS; Doronin BM; Favorova OO; Nevinsky GA; Neustroev KN
    Immunol Lett; 2003 May; 86(3):291-7. PubMed ID: 12706534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.